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ABSTRACT
Objective: The aim of this study is to determine the effect of stingless bee propolis supplementation as a hepatoprotector on the prevention of Drug-
induced liver injury (DILI) and the effect of healing and restoring nutrition for DILI patients due to drug induction.
Methods: The literature review starts from problem identification, library data collection, reading, taking notes, analyzing, and processing the data 
obtained and then compiling it into a systematic review.
Results: The results of a literature study conducted show that propolis has a good hepatoprotective ability against drugs that cause DILI cases 
such as the anti-tuberculosis, antibiotic, and antipyretic groups as indicated by the serum glutamic pyruvic transferase, serum glutamic oxaloacetic 
transferase, total bilirubin, glutathione, and superoxide dismutase values that are close to normal values. In addition, propolis supplementation can 
accelerate the healing and restoration of the nutritional status of DILI patients. All active compounds contained in propolis such as phytochemicals 
and lipopolysaccharides work to protect the liver from the toxic effects of DILI through antioxidant mechanisms.
Conclusion: Overall, the data from this literature study show that the hepatoprotective activity of propolis has the potential to complement drug 
therapy to reduce hepatotoxic effects and can conclusively beneficial to accelerate the restoration of nutritional status for DILI patients.
Keywords: Antioxidant, Drug-induced liver injury, Hepatotoxic Hepatoprotective, Propolis.
INTRODUCTION
Drug-induced liver injury (DILI) is a diagnosis in patients who have 
liver damage caused by consuming drugs that are liver damage or 
hepatotoxic [1]. DILI can be caused by drugs that are hepatotoxic 
including anti-tubercular drugs (Rifampicin, Isoniazid, and 
Pyrazinamide) [2-4], nonsteroidal anti-inflammatory drugs (Ibufenac, 
Acetaminophen) [5], anti-retroviral drugs (Ritonavir and Indinavir) [6], 
anti-hyperlipidemic drugs (Statins, Atorvastatin) [7,8], anesthetic 
agents (CCl4, Chloroform) [9], and antibiotics (tetracycline and 
monocycline) [10].
The DILI study found that antibiotic, antibacterial, and anti-tuberculosis 
drugs were drugs with high hepatotoxic effects compared to other 
drugs. Based on the diagnostic criteria for hepatotoxicity and the 
population studied, the reported incidence of anti-TB hepatotoxicity 
increased from 2% to 28% [11]. The study by the US DILIN cohort 
reported 46% cases of anti-TB hepatoxicity [10]. In India, cases of 
anti-TB hepatotoxicity were reported in 58% and cases of death due 
to hepatotoxicity of anti-TB drugs reached 9.5% [12]. For this reason, 
the WHO strongly encourages research with the main aim of finding 
new drugs to tackle drugs that are more effective and with the lower 
side effects than existing drugs [13]. At present, supplements derived 
from natural products, fruits, vegetables, herbs, and spices have 
many biological properties and have the potential to fight several 
diseases [14]. One that is starting to be developed a lot is propolis which 
has many pharmacological effects.
Propolis is a resin collected by bees from various plants, which mixes 
with saliva and various enzymes to produce a new, different resin. 
Propolis has antibacterial, anti-inflammatory, antiviral and other 
biological activities such as anti-inflammatory, local anesthetics, 
hepatoprotections, anti-tumor, and immunostimulants [15]. Animal 
studies have shown that propolis has an antimicrobial effect [16,17], 
antiviral [18,19], antifungals [20,21], anti-parasitic [22,23], anti-
inflammatory [22], and anti-tumor [24]. Propolis contains antioxidants 
and has anti-inflammatory, immunoregulatory, bacteriostatic and 
bactericidal effects [22,25]. Bhadauria et al. [26] suggested that 
propolis has the potential as a hepatoprotector in chronic liver injury 
by maintaining its antioxidant activity.
METHODS
The literature review starts from problem identification, library data 
collection, reading, taking notes, analyzing, and processing the data 
obtained and then compiling it into a systematic review. The method 
is generally divided into two stages; The first stage is the stage 
related to the data collected, consisting of: Problem identification, 
determining library sources based on eligibility criteria and 
inclusion or exclusion criteria, data collection, and sorting based on 
the suitability of the literature with the topics discussed. The second 
stage is processing the data that have passed the sorting, consisting 
of: Data analysis and interpretation and confirmation. Data that have 
been confirmed will be included in the review, while unconfirmed 
data will be re-sorted.
RESULTS AND DISCUSSION
Hepatoprotective activity of propolis
Hepatoprotectors are compounds or substances that can protect cells 
as well as repair damaged liver tissue due to toxic substances [27]. 
Free radical damage in the body can be overcome with antioxidants. 
Antioxidant is defined as a substance that can delay, prevent, or eliminate 
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oxidative damage to target molecules, for example, proteins, lipids, 
and DNA [28]. Giving hepatoprotectors can be done for prevention or 
healing (curative) [29]. Table 1 summarizes the literature data searched 
concerning hepatoprotective activity of propolis.
Studies of propolis as a hepatoprotector in vivo with the induction of 
hepatotoxic DILI drugs have been carried out by several researchers 
using analytical methods such as the Kruskal–Wallis test, the Mann–
Whitney Advanced Test, the ANOVA test, the Tukey HSD Advanced Test, 
and the post hoc test. In general, hepatoprotective compounds have 
high antioxidant activity [30]. High antioxidant activity will prevent fat 
peroxidation and tissue damage in the liver caused by the presence of 
incoming free radical compounds such as hydroxyl radicals, superoxide 
anions, and nitric oxide [28].
Research conducted by Mahani et al. [31] analyzed several propolis 
obtained from regions throughout Indonesia. The propolis chosen as the 
best candidate as a complementary hepatoprotector for ATD is the propolis 
Geniotrigona incisa from South Sulawesi province. This propolis has very 
high antioxidant activity to reduce hepatotoxic effects (IC50 100.05 ppm), 
low toxicity (854.75 ppm), and strong M.Tbc inhibition (49.84%).
The hepatoprotective effect of propolis with high antioxidant activity 
was also found to protect the liver from the toxic effects of taking the 
drug atorvastatin according to Abdelsameea et al. [32]. The study using 
Egypt Native propolis was carried out on 56 albino mice divided into 
seven groups; Group I (25 mg/kg propolis in 1 ml distilled water), 
Group II (25 mg/kg atorvastatin in 1 ml distilled water), Group III 
(50 mg/kg propolis in 1 ml suspension + 20 mg/kg atorvastatin in 1 ml 
distilled water), Group IV (100 mg/kg propolis + 20 mg/kg atorvastatin 
in 1 ml distilled water), Group V (80 mg/kg atorvastatin in 1 ml distilled 
water), Group VI (50 mg/kg propolis in 1 ml suspension + 80 mg/kg 
atorvastatin in 1 ml distilled water), and Group VII (100 mg/kg propolis 
in 1 ml suspension + 80 mg/kg atorvastatin in 1 ml distilled water).
After 1 month, hepatocyte degradation was obtained at a dose of 
20 mg/kg and 80 mg/kg of Atorvastatin. Atorvastatin can cause acute 
hepatotoxicity, especially in women aged over 60 years [33]. The group 
treated with the addition of 50 mg/kg and 100 mg/kg of propolis 
showed a significant decrease in serum alanine aminotransferase (ALT), 
aspartate aminotransferase (AST) levels and catalase enzyme activity 
(CAT), and superoxide dismutase (SOD) as biomarkers of hepatocyte 
degradation. The addition of propolis treatment can protect the liver 
from oxidative stress that occurs due to Atorvastatin administration. 
Banskota et al. [34] stated that the hepatoprotective effect of propolis 
can help reduce D-galactosamines which trigger tumor necrosis in rat 
hepatocytes. Omar et al. [35] added that Egypt Native propolis has 
been shown to have a hepatoprotective effect against the anticancer 
agent Doxorubicin which causes side effects such as cardiotoxicity, 
hepatotoxicity, and nephrotoxicity in mice. Polyphenol compounds that 
act as antioxidants can protect liver tissue damage from oxidative stress 
caused by consuming drugs.
Table 1: Hepatoprotection activity of propolis




Clinical assay  
(TB patient)
ATD (Rifampicin, Isoniazid, 
Pirazinamid, Etambutol)
Kruskal Wallis Test 
and Mann Whitney 
Advanced Test





In vivo assay 
(Wistar strain 
male white rat)
Chlorampenicol ANOVA and Tukey HSD 
Advanced Test





In vivo assay 
(Sprague-Dawley 
strain adult male 
rat)
Streptozotosin (STZ) ANOVA and Tukey HSD 
Advanced Test





In vivo assay 
(Swiss strain 
male and female 
rats)
No induction ANOVA and Tukey HSD 
Advanced Test










Kruskal Wallis Test Macroscopic observation 
and histopathological 
assessment
(Hasan et al., 2014)
Ekstrak etil asetat 
propolis Apis 
mellifera.
Uji in vivo (pada 
tikus galur 
Wistar)
Epirubicin (antibiotik) Uji ANOVA (AST, ALT, SOD, CAT, GSH) (Chaa et al., 2019)
Egypt Native 
Propolis
In vivo assay 
(albino male and 
female rats)
Atorvastatin ANOVA and Post-hoc 
Test





In vivo assay 
(Sprague-Dawley 
strain adult male 
rat)
Doxorubicin ANOVA Test AST, ALT, Albumin, TP 
and Histopathological 
observation




In vivo assay 
(Wistar-albino 
strain male and 
female rat)





In vivo assay 
(Wistar-albino 
strain adult male 
rat)
Tetracycline ANOVA and Tukey HSD 
Advanced Test
SGPT, SGOT, ALB, BT, 
TC, TG




In vivo assay 
(Swiss Albino 
strain male rat)
Octylphenol ANOVA Test AST, ALT, BT, SOD, GAT (Saleh, 2012)
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EFFECT OF PROPOLIS ON DRUG TOXICITY IN LIVER
Based on the literature studies, the drugs with the most potential in DILI 
and still widely used are the Anti-Tuberculosis (ATD) types Rifampicyn 
and Isoniazid which have hepatotoxicity side effects. Some researchers 
have found new types of OAT that have a lower hepatotoxicity effect 
such as quinolone drugs (moxifloxacin and levofloxacin). However, 
these drugs cause resistance and are quite expensive. Isoniazid itself 
can produce acetyl hydrazine and hydrazine by N-asetyl transferase and 
amide hydrolysis enzymes which are toxic metabolites and a strong liver 
inducer [36]. Consumption of isoniazid together with rifampicin will 
cause rifampicyn toxicity to the liver, and significantly reduce the survival 
rate of liver cells [31]. The hepatotoxicity of rifampicyn increases sharply 
when combined with isoniazid, which is characterized by an increase in 
acetylhydrazine and hydrazine. Both are toxic metabolites. The mechanism 
of rifampicyn hepatotoxicity is mediated by oxidative damage [37] while 
rifampicyn hepatotoxicity through increased ALT concentration and other 
disorders causes the accumulation of bilirubin [3].
Anti-tuberculosis drugs are known to be hepatotoxic which is 
characterized by an increase in the concentration of serum glutamic 
pyruvic transferase (SGPT) biomarkers, serum glutamic oxaloacetic 
transferase (SGOT), total bilirubin (BT), ALP and decreased 
concentrations of SOD, Glutathione (GSH), glutathione peroxidase 
(GPx), and CAT [38]. Clinically the symptoms of ATD toxicity are 
decreased appetite, decreased body weight (BW), insomnia, skin rash, 
nausea/vomiting, diarrhea, epigastric pain, fatigue, dizziness/headache, 
fever, peripheral neuropathy, and dysmenorrhea [39,40]. Free radical 
activity in TB patients who consumed ATD was very high and had low 
antioxidant status. This occurs because the oxidative stress mechanism 
to fight M.tbc infection causes depletion of antioxidants. Propolis has 
been widely researched and is able to provide hepatoprotective effects 
both in vitro, in vivo, and clinically. Research conducted by Bhadauria 
et al. [41], Hashmi et al. [42], Cevik et al. [43], and Omar et al. [35] 
showed that propolis is an antioxidant and can protect the liver from 
the toxic effects of drugs and ATD. The effectiveness of propolis in 
protecting the liver from the hepatotoxicity effects of AOT can be seen 
from its biomarkers, namely, SGPT, SGOT, BT, GSH, and SOD.
EFFECT OF PROPOLIS ON SGPT LEVEL
Effect of propolis on SGPT level has described by Mahani et al. [31] 
clinically in three groups, Group P0 (ATD + propolis placebo), P1 (ATD 
+ propolis 6%), and P2 (ATD + propolis 30%). During the intervention, 
Group P2 experienced the greatest decrease in SGPT and conversely, 
Group P0 experienced the smallest decrease in SGPT. This shows that 
the greater the concentration of propolis supplementation, the greater 
the ability to reduce liver toxicity.
These results are in line with the study conducted by Tanvir et al. [44]. 
SGPT concentrations in the treatment with Tetracycline (TTC) and 
Bangladeshi propolis were found to be significantly lower when 
compared to the TTC treatment in rats. TTC is toxic to the liver and can 
cause necrosis of hepatocytes and an inflammatory reaction [45,46]. 
Provision of propolis can maintain the integrity of the membrane and 
inhibits the leakage of enzymes in the blood. This protective mechanism 
is related to the presence of phenolic compounds (gallic acid, benzoic 
acid, salicylic acid, pyrogallol, and routine), tannins, ascorbic acid, 
(Mahani et al., 2018)
 Fig. 1: Average change of the serum glutamic pyruvic transferase 
concentration Group P0 (ATD + Propolis placebo), P1 (ATD + 
Propolis 6%) and P2 (ATD + Propolis 30%) (Mahani et al., 2018)
Fig. 2: Average change of the serum glutamic oxaloacetic 
transferase concentration Group P0 (ATD + Propolis placebo),  
P1 (ATD + Propolis 6%), and P2 (ATD + Propolis 30%)  
Fig. 4: Average change of the Glutathione concentration in 
Group P0 (ATD + Propolis placebo), P1 (ATD + Propolis 6%), and 
P2 (ATD + Propolis 30%)
Fig. 3: Average change of total bilirubin concentration in Group P0 
(ATD + Propolis placebo), P1 (ATD + Propolis 6%), and  
P2 (ATD + Propolis 30%)
Fig. 5: Average change of the superoxide dismutase concentration 
in Group P0 (ATD + Propolis placebo), P1 (ATD + Propolis 6%), 
and P2 (ATD + Propolis 30%)
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and Vitamin E in propolis extract which have inhibitory activity on 
membrane fat peroxidation with strong antioxidant activity [47-49].
These results are also supported by the research of Saleh [50] which 
states that aqueous extract of propolis can reduce the damage and 
hepatotoxicity effects on liver cells induced by 4-tertiary-octylphenol 
(4-tert-OP). ALT levels in mice given 4-tert-OP induction showed a 
significant increase when compared to controls, while mice given 
propolis extract had lower ALT levels than controls. In this case, 
propolis is believed to help repair liver damage caused by 4-tert-
OP. The flavonoid compounds in propolis have been shown to have 
a hepatoprotective effect by binding to heavy metal ions thereby 
suppressing the formation of free radicals.
EFFECT OF PROPOLIS ON SGOT LEVEL
Besides SGPT, Mahani et al. [31] also measured the concentration of 
SGOT in three groups. The SGOT concentrations in the P0 and P2 groups 
experienced a surge in the eighth week, increasing 0.44 and 0.87 U/l, 
respectively. This is in contrast to the previous SGPT concentration. In 
the P1 group, it actually experienced a decrease of 1.93 U/l. SGOT, like 
SGPT, is indispensable in medicine because it acts as a protein metabolite 
transporter [30]. The increase in SGOT is the body’s homeostasis 
mechanism to carry out the optimal biotransformation of metabolites 
for treatment. ATD consumption will produce large amounts of ATD 
radical metabolites. This metabolite is needed to kill M.tbc. one of 
the ATDs that are often used and known to be very toxic is isoniazid. 
The compounds in these drugs are considered foreign by the body, so 
they are converted by the liver into metabolites, namely, hydrazine, 
acetyl hydrazine and monoacetyl hydrazine. These metabolites are 
more soluble and can be accepted by the body, but are radical and 
toxic [37,51]. This radical nature will kill M.tbc. The transformation of 
drug compounds into various metabolite compounds is carried out by 
transporter proteins, namely, SGPT and SGOT.
This is in line with the research of Mahdi et al. [30] that showed 
the provision of Trigona sp. can reduce SGOT and ALP levels 
significantly in Chloramphenicol-induced rats. Chloramphenicol 
in large doses will damage liver cells and increase SGOT and SGPT 
levels. According to Saba et al. [52], Chloramphenicol has been 
shown to have a hepatotoxic effect, causing elevated levels of liver 
enzymes in the blood. This study was conducted in five groups; 
negative control, positive control (400 mg/kgBW Chloramphenicol), 
Group I (400 mg/kgBW Chloramphenicol + 8 mg propolis), Group II 
(400 mg/kgBW Chloramphenicol + 16 mg propolis), and Group III 
(400 mg/kgBW Chloramphenicol + 24 mg propolis). In the negative 
control, the SGOT concentration was in the normal range. This is 
because the body is able to balance the number of free radicals and 
antioxidants. The highest SGOT concentration was found in positive 
control. This is due to increased oxidative stress in the body due to 
Chloramphenicol.
Another study conducted by Ambardekar et al. [53] using propolis 
liposomes in mice induced by acetaminophen or better known as 
paracetamol. The liver damage in mice in this study was caused by 
the toxic metabolite N-acetyl-p-benzoquinone imine (NAPQI) which is 
produced as a result of biotransformation using the enzyme cytochrome 
P450 as a catalyst. Under normal conditions, this metabolite is 
detoxified by GSH. However, high doses of Paracetamol cause an 
increase in NAPQI so that the detoxification process is ineffective 
and causes liver cell damage [54]. The results of this study showed 
that the AST concentration in the group treated with the addition of 
propolis liposomes was lower than the group treated with Paracetamol 
induction. Even the AST concentration in the group treated with the 
addition of propolis liposomes was still lower than the group treated 
with the addition of ordinary propolis. This showed that propolis in the 
form of liposomes is more effective as a hepatoprotective agent than 
ordinary propolis. Propolis in the form of liposomes is more easily 
absorbed by the tissue because it is nanoparticle size and has a bilayer 
structure that matches the structure of the cell membrane.
EFFECT OF PROPOLIS ON BT LEVEL
Research conducted by Mahani et al. [31] measured BT concentrations 
in three groups. Normal BT concentrations range from 0.3 to 1.2 mg%. 
On the other hand, the P1 and P2 groups (the propolis supplementation 
group) experienced a decrease in BT, namely, 1.05 and 0.91 mg%, 
respectively. This suggests that administration of propolis can prevent 
oxidative damage to the liver during the intensive treatment phase. At 
the advanced treatment stage, BT continued to decline in all groups. At 
week 24 the BT concentrations of the P0, P1, and P2 groups decreased, 
namely, by 0.81, 0.88, and 0.70 mg%. The BT concentration in the P2 
group was the lowest compared to other groups. This suggests that high 
doses of propolis supplementation are effective in protecting the liver 
from oxidative damage due to the hepatotoxic effects of ATD. From SGPT, 
SGOT, and BT values as a whole, it is clear that the P2 group did not show 
hepatotoxicity and on the other hand the P0 group showed hepatotoxicity.
These results were also substantiated by the work of of Nna et al. [55] 
with Malaysian propolis in Streptozotocin (STZ)-induced mice. 
According to Graham et al. [56] diabetes disease induced from STZ. STZ 
is a glucosamine-nitrosourea compound produced from Streptomyces 
achromogenes which is used clinically as chemotherapy in pancreatic 
β-cell carcinoma. Diabetes mellitus (DM) can cause oxidative stress in 
the liver by producing auto-oxidation of glucose and increasing levels 
of ROS [57,58]. DM is reported to reduce SOD, CAT, GPx, glutathione-
S-transferase (GST), and glutathione reductase (GR) [59,60]. The 
results of this study indicated that BT levels significantly increase in 
diabetic control compared to normal control. This can be influenced by 
increased synthesis or the rate of excretion in the liver. In DC, there is 
an increase in LDH activity and causes the liver to excrete the remaining 
bilirubin resulting in the accumulation of bilirubin. The addition of 
propolis treatment can reduce BT levels in STZ-induced mice in addition 
of metformin. It can be concluded that the combination treatment of 
propolis and metformin can reduce the hepatotoxicity effect of the liver 
in DM patients.
This result is also supported by the research of Saleh [50] which states 
that aqueous extract of propolis can significantly reduce BT levels in 
liver cells induced by 4-tertiary-octylphenol (4-tert-OP) significantly. BT 
levels in mice given 4-tert-OP induction showed a significant increase 
when compared to controls, while mice given propolis extract had 
lower BT levels than controls. High BT levels on induction of 4-tert-OP 
indicate liver damage. According to El-Kott & Owayss [61] an increase 
in BT indicates widespread damage to liver cells. The treatment of 
propolis extract was able to reduce BT levels, so it can be concluded that 
propolis is hepatoprotective and can reduce the toxic effects of 4-tert-
OP on the liver.
EFFECT OF PROPOLIS ON GSH LEVEL
Mahani et al. [31] also measured GSH concentrations in three groups. 
The results showed that at the GSH concentration at the 8th week 
(the end of the intensive treatment stage), only the P2 group showed 
a GSH concentration of more than 1, which was 1008 ug/ml. The 
GSH concentrations of groups P0 and P1 were 0.93 and 0.94 ug/ml, 
respectively. The highest GSH concentration was found in the P2 group 
during the intensive treatment stage (week 1–8). On the other hand, 
the GSH concentration at the same time in the P0 and P1 groups was 
lower than the P2 group. The difference in GSH concentration indicates 
that the addition of high doses of propolis (30% concentration) can 
help reduce radical metabolites so that excessive GSH depletion can be 
avoided. It can be concluded that high doses of propolis supplementation 
can create a better GSH status than the other groups, especially in 
the intensive treatment stage and can protect the liver from the toxic 
effects of ATD. Similar results were described by Banudevi et al. 
(2005), Chowdhury et al. (2006), and Palanisamy et al. (2011) High 
GSH concentrations are an indication of hepatoprotectivity. About 30% 
propolis supplementation can protect the liver from the hepatotoxic 
effects of ATD and create good liver antioxidant enzyme status during 
the intensive treatment phase.
90
Asian J Pharm Clin Res, Vol 14, Issue 12, 2021, 86-92
 Mahani et al.
Nna et al. (2018) demonstrated same result with Malaysian propolis in 
STZ-induced mice. Chronic diabetes can cause major tissue damage to 
the liver by increasing oxidative stress [65,66], inflammation [57,66,67], 
and apoptosis [66,67]. In addition, DM can reduce levels of GPx, GST, 
and GR [59,60]. The results of this study indicated that GSH levels in 
Groups I, II, and III increased when compared to DC. The highest GSH 
levels were found in Group III. It can be concluded that the treatment of 
propolis and metformin is most effective in increasing the antioxidant 
status of the liver.
Similar results were also shown in the study of Chaa et al. [68]. In this 
study, epirubicin as an antibiotic increased biomarker compounds 
of oxidative stress in the liver (lipid peroxidation) and decreased 
endogenous antioxidant agents such as GSH, catalase, and SOD 
activity. Propolis from Tigzirt managed to restore this oxidative 
stress in liver tissue. This antioxidant effect is due to the presence 
of phenolic acids and flavonoids in propolis, as well as its ability to 
scavenge free radicals. The group of rats that were given propolis 
supplementation 250 mg/kg for 19 days showed a significant increase 
(86.51 U/g) compared to the control (76.08 U/g). The group of rats 
that were only given epirubicin showed a significant decrease in GSH 
levels (12.78 U/g) compared to the control group. This shows that the 
ethyl acetate propolis extract is able to restore the antioxidant status 
of the epirubicin-induced liver.
EFFECT OF PROPOLIS ON SOD LEVEL
Based on research conducted by Mahani et al. [31], the P2 group 
shows the highest SOD concentration in the 8th week (end of the 
intensive treatment stage) with a concentration of 0.372 U/ml plasma. 
While the P0 and P1 groups had only 0.318 and 0.256 U/ml plasma 
concentrations, respectively. At week 24 (end of intervention), P2 
group had increased SOD to 0.708 U/ml plasma. Meanwhile, the SOD 
concentrations of the P0 and P1 groups were only 0.526 and 0.461 U/
ml of plasma. This shows that the presence of high doses of propolis can 
create a better antioxidant enzyme status than the other groups and 
is a strong indication of hepatoprotectivity. This result is in line with 
Ramappa and Aithal [51] and Tostmann et al. [3] which stated that SOD 
restoration is an indication of hepatoprotectivity.
This result is also similar with the research done by Nna et al. [55] The 
results of this study indicate that the levels of SOD in Groups I, II, and 
III have increased when compared to DC. The highest SOD levels were 
found in Group III. It can be concluded that the treatment of propolis 
and metformin is most effective in increasing the antioxidant status of 
the liver. Propolis is able to improve the antioxidant status of the liver 
directly, indirectly, or both. Directly, propolis can directly trap ROS in 
the liver. Indirectly, propolis can increase the antioxidant status of the 
liver by reducing levels of fasting blood glucose so that it will limit 
the formation of ROS. An increase in antioxidant enzymes in diabetes 
models with the addition of propolis treatment was also found in 
studies using propolis from Taiwan [69], Egypt [70], China [71,72], and 
Brazil [72].
EFFECT OF PROPOLIS ON NUTRITIONAL STATUS
Based on the literature studies, the effects of propolis for TB sufferers 
include the ability to fight M.tbc infection and synergize with OAT so that 
it has the potential as an ingredient to accelerate the healing process for 
pulmonary tuberculosis sufferers. In addition, the ability of propolis as 
a hepatoprotector has the potential to protect the hepatotoxic effects of 
OAT which, in turn, is useful for accelerating the recovery process of the 
nutritional status of patients with pulmonary tuberculosis. Restoration 
of nutritional status of patients with pulmonary tuberculosis can be 
measured by knowing changes in BW and body mass index (BMI) [31].
One of the nutritional statuses that are measured to determine 
the effect of propolis is BW. Based on a study conducted by Mahani 
et al. [31], the OAT induction group without propolis supplementation 
experienced a decrease in BW until the 4th week. This reduction 
in BW is strongly thought to be due to the hepatotoxic effect of OAT, 
namely nausea, dizziness, and decreased appetite, so that the intake of 
nutrients is lower than normal. When compared with other groups, the 
OAT induction group with propolis supplementation did not experience 
a decrease in BW and immediately increased since the beginning of 
the intervention. This increase in BW is thought to be due to the fact 
that 30% propolis supplementation was effective in reducing the 
hepatotoxic effect of standard doses of OAT. The results of this study 
indicate a strong indication that the intensive use of OAT has an effect 
on reducing BW through the hepatotoxic mechanism.
Intensive administration of OAT can reduce a person’s nutritional 
status as a result of the hepatotoxic effect. In contrast, supplementation 
of 20 drops of propolis with a concentration of 30% on OAT can reduce 
the effects of decreasing nutritional status due to OAT consumption. 
Even being able to improve the nutritional status of the subject is 
better than the base line. This shows a strong indication that propolis 
supplementation with a concentration of 30% in OAT every day 
can accelerate the recovery of the subject’s nutritional status. The 
recovery of BW and BMI is faster and greater as shown by the high-
dose propolis group which is able to reduce nausea since the beginning 
of the intervention. In addition, the recovery of their weight and body 
mass is also an indication that their nutrients are no longer used to 
fight infection as a result of their recovery in the 5th week. The effect is, 
after the 5th week these nutritional resources are used to restore their 
nutritional status.
This is confirmed by the research of Chaa et al. [68]. A very 
significant weight loss occurred in mice that received only epirubicin 
(G1) injections. G4 mice (rats given 250 mg/kg EAP) experienced 
significant weight gain up to the 19th day of supplementation. Mice in 
G1 (control) and G4 did not show any behavioral changes indicating 
that propolis extract could inhibit epirubicin hepatotoxicity. 
Significant changes in physical activity and behavior occurred in 
mice on G2 (which only received epirubicin) such as: Drowsiness, 
hypoactivity, hair straightening, tachycardia, difficulty breathing, and 
loss of balance.
IDENTIFICATION OF ACTIVE COMPOUNDS OF PROPOLIS AS ANTI 
HEPATOTOXICITY NUTRACEUTICAL
Based on the literature studies, there are 11 active compounds that are 
strongly suspected of having an antihepatotoxicity/antioxidant role. These 
compounds fall into two categories, namely, phytochemicals and lipids. Active 
compounds classified as phytochemicals are: (1) 2,6-Dimethoxyphenol, 
(2) Methyl-α-d-glucopyranoside, (3) 1,6-Anhydro-Beta-D-Glucopyranose, 
(4) (2S, 3R) -3-Allyl-3-methylapfelsaure-4-ethylester, 
(5) 5-Azulenemethanol, 1,2,3,3a, 4,5,6,7-octahydro-alpha, alpha, 
3,8-tetramethyl, and (6) 1,4,5-Trimethylnaphthalene. Like anti-
tuberculosis compounds, glycosides (methyl-alpha-D-glucopyranoside and 
1,6-Anhydro-Beta-D-Glucopyranose) also act as the main hepatoprotector 
compound with a concentration of 40.57%. While active compounds 
classified as lipids are: (1) Tridecanoic acid, (2) Tetra decanoic acid, (3) 
Pentadecanoic acid, and (4) Hexadecenoic acid. 2,6-dimethoxyphenol [73], 
1,6-anhydro-beta-d-glucopyranose compounds [74], (2S, 3R) -3-Allyl-
3-methylapfelsaure-4 -ethylester [75,76], 1,4,5-trimethylnaphthalene 
showed reduction of 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical 
compounds. They can work to reduce radical metabolites by binding to 
them. Likewise, methyl-α-d-glucopyranoside and 5-azulenemethanol, 
1,2,3,3a, 4,5,6,7-octahydro-alpha, alpha, and 3,8-tetramethyl compounds 
act as hepatoprotectors. They work by reducing radical metabolites. This 
is based on the results of research by Kokanova-Nedialkova et al. [77] and 
Vinholes et al. [78] which showed that the two compounds had a strong 
ability to reduce radical compounds (DPPH). Glycerol (propanetriol) is 
a lipid compound that acts as a hepatoprotector, but is not antioxidant. 
Glycerol has the ability to strengthen membranes and cell walls to deliver 
antibacterial agents [79]. This role is very important because it can protect 
the membranes and cell walls of the liver, which interact a lot with radical 
metabolites used to fight M.tbc.
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CONCLUSION
Supplementation of stingless bee propolis has been shown to act as a 
hepatoprotector and has a positive effect on patients with drug-induced 
DILI by reducing liver oxidative damage, which is characterized by 
decreased levels of SGPT, SGOT, and BT as well as increased levels of 
SOD and GSH. Supplementation of bee propolis without stingers has 
been proven to reduce liver infection so that the nutrients possessed 
can be used to restore the nutritional status of DILI patients, which 
is characterized by increased BMI and BB values at the end of the 
intervention.
ACKNOWLEDGMENTS
The authors express gratitude to the Faculty of Agric. Industrial 
Technology of Universitas Padjadjaran for facilitating the research.
CONFLICT OF INTEREST
The authors declare no conflict of interest associated with this study.
1. Björnsson ES. Hepatotoxicity by drugs: The most common implicated 
agents. Int J Mol Sci 2016;17:224.
2. Nishimura Y, Kurata N, Sakurai E, Yasuhara H. Inhibitory effect of 
antituberculosis drugs on human cytochrome P450-mediated activities. 
J Pharmacol Sci 2004;96:293-300.
3. Tostmann A, Boeree MJ, Aarnoutse RE, De Lange WC, Van Der 
Ven AJ, Dekhuijzen R. Antituberculosis drug‐induced hepatotoxicity: 
Concise up‐to‐date review. J Gastroenterol Hepatol 2008;23:192-202.
4. Wen X, Wang JS, Neuvonen PJ, Backman JT. Isoniazid is a mechanism-
based inhibitor of cytochrome P 450 1A2, 2A6, 2C19 and 3A4 isoforms 
in human liver microsomes. Eur J Clin Pharmacol 2002;57:799-804.
5.  Lewis  JH,  Stine  JG.  Nonsteroidal  antiinflammatory  drugs  and 
leukotriene receptor antagonists. In: Drug-Induced Liver Disease. 
Amsterdam, Netherlands: Elsevier; 2013. p. 369-401.
6. Bonfanti P, Landonio S, Ricci E, Martinelli C, Fortuna P, Faggion I, 
et al.  Risk  factors  for  hepatotoxicity  in  patients  treated  with  highly 
active antiretroviral therapy. JAIDS J Acquir Immune Defic Syndr 
2001;27:316-8.
7.  Jiménez-Alonso  J,  Osorio  JM,  Gutiérrez-Cabello  F,  de  la  Osa  AL, 
León  L,  García  JD.  Atorvastatin-induced  cholestatic  hepatitis  in  a 




9.  Njoku  D,  Laster  MJ,  Gong  DH,  Eger  EI,  Reed  GF,  Martin  JL. 
Biotransformation of halothane, enflurane, isoflurane, and desflurane 
to  trifluoroacetylated  liver  proteins:  Association  between  protein 
acylation and hepatic injury. Anesth Analg 1997;84:173-8.
10. Chalasani N, Fontana RJ, Bonkovsky HL, Watkins PB, Davern T, 
Serrano J, et al. Causes, clinical features, and outcomes from a 
prospective study of drug-induced liver injury in the United States. 
Gastroenterology 2008;135:1924-4.e4.
11.  Girling DJ. The hepatic toxicity of antituberculosis regimens containing 
isoniazid, rifampicin and pyrazinamide. Tubercle 1977;59:13-32.
12. Devarbhavi H, Dierkhising R, Kremers WK, Sandeep MS, Karanth D, 
Adarsh  CK.  Single-center  experience with  drug-induced  liver  injury 
from India: Causes, outcome, prognosis, and predictors of mortality. 
Am J Gastroenterol 2010;105:2396-404.
13.  World Health Organization. Global Tuberculosis Report 2013. Geneva: 
World Health Organization; 2013.
14. Khan R, Sultana S. Farnesol attenuates 1, 2-dimethylhydrazine induced 
oxidative stress, inflammation and apoptotic responses in the colon of 
Wistar rats. Chem Biol Interact 2011;192:193-200.
15.  Bankova  V,  Popova  M,  Bogdanov  S,  Sabatini  AG.  Chemical 
composition of European propolis: Expected and unexpected results. 
Z Naturforschung C 2002;57:530-3.
16. Alencar SM, Oldoni TC, Castro ML, Cabral IS, Costa-Neto CM, 
Cury JA, et al. Chemical composition and biological activity of a 
new  type  of  Brazilian  propolis:  Red  propolis.  J  Ethnopharmacol 
2007;113:278-83.
17. Fernandes A Jr., Balestrin EC, Betoni JE, de Orsi RO, de Cunha ML, 
Montelli AC. Propolis: Anti-Staphylococcus aureus activity and 
synergism  with  antimicrobial  drugs.  Mem  Inst  Oswaldo  Cruz 
2005;100:563-6.
18.  Amoros  M,  Lurton  E,  Boustie  J,  Girre  L,  Sauvager  F,  Cormier  M. 
Comparison of the anti-herpes simplex virus activities of propolis and 
3-methyl-but-2-enyl caffeate. J Nat Prod 1994;57:644-7.
19. Serkedjieva J, Manolova N, Bankova V. Anti-influenza virus effect of 
some propolis constituents and their analogues (esters of substituted 
cinnamic acids). J Nat Prod 1992;55:294-7.
20. Murad JM, Calvi SA, Soares A, Bankova V, Sforcin JM. Effects 
of propolis from Brazil and Bulgaria on fungicidal activity of 
macrophages against Paracoccidioides brasiliensis. J Ethnopharmacol 
2002;79:331-4.
21. Tosi B, Donini A, Romagnoli C, Bruni A. Antimicrobial activity of 
some commercial extracts of propolis prepared with different solvents. 
Phytother Res 1996;10:335-6.
22. Ansorge S, Reinhold D, Lendeckel U. Propolis and some of its 
constituents down-regulate DNA synthesis and inflammatory cytokine 
production  but  induce  TGF-β1 production of human immune cells. 
Z Naturforschung C 2003;58:580-9.
23. De Castro SL, Higashi KO. Effect of different formulations of 
propolis on mice infected with Trypanosoma cruzi. J Ethnopharmacol 
1995;46:55-8.
24. Bankova V. Recent trends and important developments in propolis 
research. Evid Based Complement Altern Med 2005;2:29-32.
25. Tsai FH, Lien JC, Lin LW, Chen HY, Ching H, Wu CR. Protective 
effect of Broussonetia papyrifera against hydrogen peroxide-induced 
oxidative stress in SH-SY5Y cells. Biosci Biotechnol Biochem 
2009;73:1933-9.
26. Bhadauria M, Nirala SK, Shukla S. Duration-dependent hepatoprotective 
effects of propolis extract against carbon tetrachloride-induced acute 
liver damage in rats. Adv Ther 2007;24:1136-45.
27.  Panjaitan RG. Pengujian Aktivitas Hepatoprotektor Akar Pasak Bumi 
(Eurycoma longifolia Jack.). Bogor: Disertasi Inst Pertan Bogor; 2008.
28.  Halliwell B, Gutteridge  JC. Lipid peroxidation, oxygen  radicals,  cell 
damage, and antioxidant therapy. Lancet Br Ed 1984;8391:1396-7.
29. Kumarappan C, Vijayakumar M, Thilagam E, Balamurugan M, 
Thiagarajan M, Senthil S, et al. Protective and curative effects 
of polyphenolic extracts from Ichnocarpus frutescense leaves on 
experimental hepatotoxicity by carbon tretrachloride and tamoxifen. 
Ann Hepatol 2016;10:63-72.
30. Mahdi C, Zukiaturrahmah A, Pratama DA, Nugraheni PW. Trigona 
sp. propolis ethanolic extract decreased chloramphenicol-induced 
serum glutamic oxaloacetic transaminase and alkaline phosphatase 
levels of rats (Rattus novergicus). Indones J Cancer Chemoprevention 
2018;9:110-7.
31.  Mahani  M,  Sulaeman  A,  Anwar  F,  Damanik  MR,  Hardinsyah  H, 
Ploeger A. Efficacy of propolis supplementation to accelerate healing 
process and body weight recovery of pulmonary tuberculosis patients. 
J Gizi Dan Pangan 2018;13:1-10.
32. Abdelsameea A, Mahgoub L, Abdel Raouf S. Study of the possible 
hepatoprotective effect of propolis against the hepatotoxic effect of 
atorvastatin in albino rats. Zagazig Univ Med J 2013;19:1-9.
33. Clarke AT, Mills PR. Atorvastatin associated liver disease. Dig Liver 
Dis 2006;38:772-7.
34.  Banskota AH, Tezuka Y, Adnyana IK, Midorikawa K, Matsushige K, 
Message D, et al. Cytotoxic, hepatoprotective and free radical 
scavenging effects of propolis from Brazil, Peru, the Netherlands and 
China. J Ethnopharmacol 2000;72:239-46.
35. Omar NA, Allithy AN, Baghdadi H, Zolaly M, Abdel-Haleem M, 
Helmy MM, et al. Hepatoprotective effects exerted by propolis 
against doxorubicin-induced rat liver toxicity: A biochemical and 
histopathological study. Am J Cancer Prev 2016;4:36-40.
36. Zhang ZH, Tang JH, Zhan ZL, Zhang XL, Wu HH, Hou YN. Cellular 
toxicity  of  isoniazid  together  with  rifampicin  and  the  metabolites 
of  isoniazid  on  QSG-7701  hepatocytes.  Asian  Pac  J  Trop  Med 
2012;5:306-9.
37.  Yew  WW,  Leung  CC.  Antituberculosis  drugs  and  hepatotoxicity. 
Respirology 2006;11:699-707.
38.  Ma  Z,  Lienhardt  C,  McIlleron  H,  Nunn  AJ,  Wang  X.  Global 
tuberculosis drug development pipeline: The need and the reality. 
Lancet 2010;375:2100-9.
39. Sudarsanam TD, Tharyan P. Rifampicin compared to isoniazid for 
preventing active TB in HIV-negative people at risk of developing 
active TB: Implications for public health. Clin Epidemiol Glob Health 
2014;2:28-36.
40. Syaripuddin M, Yuniar Y, Sari ID. Studi monitoring efek samping obat 
antituberkulosis  fdc kategori 1 di Provinsi Banten dan Provinsi  Jawa 
Barat. Med Penelit Pengemb Kesehat 2014;24:20692.
 REFERENCES
92
Asian J Pharm Clin Res, Vol 14, Issue 12, 2021, 86-92
 Mahani et al.
41. Bhadauria M, Nirala SK, Shukla S. Duration-dependent hepatoprotective 
effects of propolis extract against carbon tetrachloride-induced acute 
liver damage in rats. Adv Ther 2007;24:1136-45.
42. Hashmi N, Muhammad F, Javed I, Khan JA, Khan MZ, Khaliq T, et al. 
Nephroprotective effects of Ficus religiosa Linn (peepal plant) stem 
bark against isoniazid and rifampicin induced nephrotoxicity in albino 
rabbits. Pak Vet J 2013;33:330-4.
43. Cevik MU, Acar A, Tanriverdi H, Varol S, Arikanoglu A, Yucel Y, 
et al. Toxic effects of isoniazid and rifampicin on rat brain tissue: 
The preventive role of caffeic acid phenethyl ester. Int J Pharmacol 
2012;8:555-60.
44. Tanvir EM, Hasan MA, Nayan SI, Islam T, Ahmed T, Hossen MS, et al. 
Ameliorative effects of ethanolic constituents of Bangladeshi propolis 
against  tetracycline‐induced hepatic and renal  toxicity  in rats. J Food 
Biochem 2019;43:e12958.
45. Hossen MS, Tanvir EM, Prince MB, Paul S, Saha M, Ali MY, et al. 
Protective mechanism of turmeric (Curcuma longa) on carbofuran-
induced hematological and hepatic toxicities in a rat model. Pharm Biol 
2017;55:1937-45.
46. Paul S, Islam M, Tanvir EM, Ahmed R, Das S, Rumpa NE, et al. 
Satkara (Citrus macroptera) fruit protects against acetaminophen-
induced hepatorenal toxicity in rats. Evid Based Complement Alternat 
Med 2016;2016:9470954.
47. Ahmed R, Tanvir EM, Hossen M, Afroz R, Ahmmed I, Rumpa NE, 
et al. Antioxidant properties and cardioprotective mechanism of 
Malaysian propolis in rats. Evid Based Complement Alternat Med 
2017;2017:5370545.
48.  Paulino N, Barbosa AP, Paulino AS, Marcucci MC. Hepatoprotective 
effect of green propolis  is  related with antioxidant action  in vivo and 
in vitro. Oxid Antioxid Med Sci 2014;3:43-50.
49. Tanvir EM, Hossen MS, Shapla UM, Mondal M, Afroz R, Mandal M, 
et al. Antioxidant, brine shrimp lethality and analgesic properties of 
propolis from Bangladesh. J Food Biochem 2018;42:e12596.
50. Saleh EM. Antioxidant effect of aqueous extract of propolis on 
hepatotoxicity induced by octylphenol in male rats. Acta Toxicol 
Argent 2012;20:68-81.
51.  Ramappa  V,  Aithal  GP.  Hepatotoxicity  related  to  anti-tuberculosis 
drugs: Mechanisms and management. J Clin Exp Hepatol 2013;3:37-49.
52. Saba AB, Ola-Davies O, Oyeyemi MO, Ajala O. The toxic effects of 
prolonged administration of chloramphenicol on the liver and kidney of 
rats. Afr J Biomed Res 2000;3:133-7.
53. Ambardekar RV, Mahadik KR, Paradkar AR, Harsulkar AM. 
Enhancement of hepatoprotective efficacy of propolis by fabrication of 
liposomes, as a platform nano-formulation for multi-component natural 
medicine. Curr Drug Deliv 2012;9:477-86.
54. Wallace JL. Acetaminophen hepatotoxicity: NO to the rescue. Br J 
Pharmacol 2004;143:1-2.
55. Nna VU, Bakar AB, Mohamed M. Malaysian propolis, metformin 
and their combination, exert hepatoprotective effect in streptozotocin-
induced diabetic rats. Life Sci 2018;211:40-50.
56.  Graham ML,  Janecek  JL,  Kittredge  JA,  Hering  BJ,  Schuurman  HJ. 
The streptozotocin-induced diabetic nude mouse model: Differences 
between animals from different sources. Comp Med 2011;61:356-60.
57. Lin X, Zhang Z, Chen JM, Xu YY, Ye HR, Cui J, et al. Role of APN and 
TNF-alpha in Type 2 diabetes mellitus complicated by nonalcoholic 
fatty liver disease. Genet Mol Res 2015;14:2940-6.
58.  Muruganathan  U,  Srinivasan  S,  Vinothkumar  V.  Antidiabetogenic 
efficiency of menthol, improves glucose homeostasis and attenuates 
pancreatic β-cell apoptosis in streptozotocin-nicotinamide induced 
experimental rats through ameliorating glucose metabolic enzymes. 
Biomed Pharmacother 2017;92:229-39.
59.  Foster  SR,  Dilworth  LL,  Thompson  RK,  Alexander-Lindo  RL, 
Omoruyi FO. Effects of combined inositol hexakisphosphate and 
inositol supplement on antioxidant activity and metabolic enzymes 
in the liver of streptozotocin-induced Type 2 diabetic rats. Chem Biol 
Interact 2017;275:108-15.
60. Palsamy P, Sivakumar S, Subramanian S. Resveratrol attenuates 
hyperglycemia-mediated oxidative stress, proinflammatory 
cytokines and protects hepatocytes ultrastructure in streptozotocin-
nicotinamide-induced experimental diabetic rats. Chem Biol Interact 
2010;186:200-10.
61.  El-Kott  AF,  Owayss  AA.  Protective  effects  of  propolis  against  the 
amitraz hepatotoxicity in mice. J Pharmacol Toxicol 2008;35:402-8.
62. Banudevi S, Arunkumar A, Sharmila M, Senthilkumar J, 
Balasubramanian K, Srinivasan N, et al. Diallyl disulfide-induced 
modulation  of  a  few  phase  I  and  II  drug  metabolizing  enzymes  on 
Aroclor 1254 toxicity in Rattus norvegicus liver and ventral prostate. 
J Clin Biochem Nutr 2005;36:59-65.
63.  Chowdhury  A,  Santra  A,  Bhattacharjee  K,  Ghatak  S,  Saha  DR, 
Dhali GK. Mitochondrial oxidative  stress and permeability  transition 
in isoniazid and rifampicin induced liver injury in mice. J Hepatol 
2006;45:117-26.
64.  Palanisamy  GS,  Kirk  NM,  Ackart  DF,  Shanley  CA,  Orme  IM, 
Basaraba RJ. Evidence for oxidative stress and defective antioxidant 
response in guinea pigs with tuberculosis. PLoS One 2011;6:e26254.
65.  Gezginci-Oktayoglu  S,  Basaraner  H,  Yanardag  R,  Bolkent  S.  The 
effects of combined treatment of antioxidants on the liver injury in STZ 
diabetic rats. Dig Dis Sci 2009;54:538-46.
66.  Giribabu  N,  Karim  K,  Kilari  EK,  Kassim  NM,  Salleh  N.  Anti-
inflammatory, antiapoptotic and proproliferative effects of Vitis 
vinifera seed ethanolic extract in the liver of streptozotocin-
nicotinamide-induced Type 2 diabetes in male rats. Can J Diabetes 
2018;42:138-49.
67. Haligur M, Topsakal S, Ozmen O. Early degenerative effects of diabetes 
mellitus on pancreas, liver, and kidney in rats: An immunohistochemical 
study. Exp Diabetes Res 2012;2012:120645.
68.  Chaa  S,  Boufadi  MY,  Keddari  S,  Benchaib  AH,  Soubhye  J,  Van 
Antwerpen  P,  et al. Chemical composition of propolis extract and 
its effects on epirubicin-induced hepatotoxicity in rats. Rev Bras 
Farmacogn 2019;29:294-300.
69. Chen LH, Chien YW, Chang ML, Hou CC, Chan CH, Tang HW, et al. 
Taiwanese  green  propolis  ethanol  extract  delays  the  progression  of 
Type 2 diabetes mellitus in rats treated with streptozotocin/high-fat diet. 
Nutrients 2018;10:503.
70. Rivera-Yañez N, Rodriguez-Canales M, Nieto-Yañez O, Jimenez-
Estrada M, Ibarra-Barajas M, Canales-Martinez MM, et al. 
Hypoglycaemic and antioxidant effects of propolis of Chihuahua in a 
model of experimental diabetes. Evid Based Complement Alternat Med 
2018;2018:4360356.
71. Fuliang HU, Hepburn HR, Xuan H, Chen M, Daya S, Radloff SE. 
Effects of propolis on blood glucose, blood lipid and free radicals in 
rats with diabetes mellitus. Pharmacol Res 2005;51:147-52.
72. Zhu W, Chen M, Shou Q, Li Y, Hu F. Biological activities of Chinese 
propolis and Brazilian propolis on streptozotocin-induced Type 1 
diabetes mellitus in rats. Evid Based Complement Alternat Med 
2011;2011:468529.
73.  Adelakun  OE,  Kudanga  T,  Green  IR,  le  Roes-Hill  M,  Burton  SG. 
Enzymatic modification of 2, 6-dimethoxyphenol for the synthesis 
of  dimers  with  high  antioxidant  capacity.  Process  Biochem 
2012;47:1926-32.
74. Shaikh MH, Subhedar DD, Khan FA, Sangshetti JN, Shingate BB. 1, 
2, 3-Triazole incorporated coumarin derivatives as potential antifungal 
and antioxidant agents. Chin Chem Lett 2016;27:295-301.
75. Escribano J, Cabanes J, Jiménez-Atiénzar M, Ibañez-Tremolada M, 




Arzate S, Chavarría A, de Lima ME, et al. Protective effects of S-allyl 
cysteine on behavioral, morphological and biochemical alterations in 
rats subjected to chronic restraint stress: Antioxidant and anxiolytic 
effects. J Funct Foods 2017;35:105-14.
77. Kokanova-Nedialkova Z, Nedialkov P, Kondeva-Burdina M, 
Simeonova R, Tzankova V, Aluani D. Chenopodium bonus-henricus 
L.-A source of hepatoprotective flavonoids. Fitoterapia 2017;118:13-20.
78.  Vinholes  J,  Rudnitskaya  A,  Gonçalves  P,  Martel  F,  Coimbra  MA, 
Rocha SM. Hepatoprotection of sesquiterpenoids: A quantitative 
structure-activity relationship (QSAR) approach. Food Chem 
2014;146:78-84.
79. Ma Y, Xin L, Tan H, Fan M, Li J, Jia Y, et al. Chitosan membrane 
dressings toughened by glycerol to load antibacterial drugs for wound 
healing. Mater Sci Eng C Mater Biol Appl 2017;81:522-31.
